FDA-approved carbon copies of brand-name drugs with expired patents—over the last 30 years, these generic drugs have saved ...

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating ...

Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating ...

Biologic medications improve inflammation in Crohns disease by blocking immune system proteins that cause it. By doing this, these drugs decrease symptoms, lower your risk of flares, and help the ...

Biologic therapies have a huge impact on psoriasis treatment, helping patients achieve clearer or clear skin, although issues ...

Pregnant women who take biologic medication for rheumatoid arthritis are not running the risk of their infant developing serious/opportunistic infections, according to research presented at the 2017 ...

Strategies for integrated delivery networks (IDNs) to manage rising biologic medication costs while ensuring financial sustainability and patient outcomes are discussed during an interview with Elie M ...

The FDA recently designated Yuflyma as "interchangeable" with the popular biologic Humira for the treatment of Crohn's disease and ulcerative colitis, two types of inflammatory bowel disease (IBD), ...

Biologic drugs have improved how doctors treat serious illnesses. Instead of being made from chemicals, biologics are made from organic materials and grown in living cells. Biologic drugs are used ...

The Biologics Price Competition and Innovation Act of (BPCI Act) of 2009 granted responsibility to the FDA for review and approval of a new class of pharmaceuticals referred to as “Biosimilars.” (1) ...

PromptSE uses structured LLM prompting to generate pharmacologically relevant side-effect representations, then feeds them ...